1589004-82-9Relevant academic research and scientific papers
COMPOUND HAVING ERK KINASE INHIBITORY ACTIVITY AND USE THEREOF
-
Paragraph 0354-0355, (2020/08/20)
The invention relates to a compound of formula (I): wherein variables are as defined in the specification. The compound is an inhibitor of an ERK kinase, e.g. ERK1 and/or ERK2 kinase. The invention also relates to the use of the compound and a method for preparing the compound, and a pharmaceutical composition containing the compound.
INHIBITORS OF PROTEIN ARGININE DEIMINASES
-
, (2019/08/26)
Provided herein are inhibitors of protein arginine deiminases (PADs), pharmaceutical compositions comprising said compounds, and methods for using said compounds for the treatment of diseases.
NEW POSITIVE ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTOR
-
Page/Page column 34, (2014/04/17)
The present invention relates to indole derivatives useful in therapy, to compositions comprising said compounds, and to methods of treating diseases comprising administration of said com- pounds. The compounds referred to are positive allosteric modulators (PAMs) of the nicotinic acetylcholine α7 receptor.
